UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

PloS one, 2013, Vol.8 (6), p.e66381-e66381

2013

Volltextzugriff (PDF)

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

Brain research, 2010-11, Vol.1362 (1362), p.13-22

2010

Volltextzugriff (PDF)

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

PloS one, 2012-06, Vol.7 (6), p.e38639-e38639

2012

Volltextzugriff (PDF)

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

Journal of Neural Transmission, 2012-07, Vol.119 (7), p.789-797

2012

Volltextzugriff (PDF)

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

Neurology, 2015-10, Vol.85 (14), p.1240

2015

Volltextzugriff (PDF)

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

Neurobiology of aging, 2010-11, Vol.31 (11), p.1877-1884

2010

Volltextzugriff (PDF)

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

PloS one, 2010-12, Vol.5 (12), p.e15725-e15725

2010

Volltextzugriff (PDF)

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

Dementia and geriatric cognitive disorders, 2013-01, Vol.36 (1-2), p.99

2013

Volltextzugriff (PDF)

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

International journal of alzheimer's disease, 2010, Vol.2010, p.1-11

2010

Volltextzugriff (PDF)

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly

Dementia and geriatric cognitive disorders, 2007-01, Vol.24 (2), p.118

2007

Volltextzugriff (PDF)

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

Journal of Alzheimer's disease, 2010-01, Vol.21 (4), p.1119

2010

Volltextzugriff (PDF)

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

Neurobiology of aging, 2009-02, Vol.30 (2), p.165-173

2009

Volltextzugriff (PDF)

Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid

European archives of psychiatry and clinical neuroscience, 2020-10, Vol.270 (7), p.933-938

2020

Volltextzugriff (PDF)

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease

PloS one, 2009-07, Vol.4 (7), p.e6294-e6294

2009

Volltextzugriff (PDF)

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

European archives of psychiatry and clinical neuroscience, 2017-08, Vol.267 (5), p.391-402

2017

Volltextzugriff (PDF)

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

Neurobiology of aging, 2010-02, Vol.31 (2), p.215-223

2010

Volltextzugriff (PDF)

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment

JAMA : the journal of the American Medical Association, 2009-07, Vol.302 (4), p.385

2009

Volltextzugriff (PDF)

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity

International journal of geriatric psychiatry, 2010-04, Vol.25 (4), p.403-410

2010

Volltextzugriff (PDF)

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

JAMA psychiatry (Chicago, Ill.), 2014-10, Vol.71 (10), p.1183

2014

Volltextzugriff (PDF)

CSF biomarkers predict a more malignant outcome in Alzheimer disease

Neurology, 2010-05, Vol.74 (19), p.1531

2010

Volltextzugriff (PDF)

Low Incidence of Post-Lumbar Puncture Headache in 1,089 Consecutive Memory Clinic Patients

European neurology, 2010-01, Vol.63 (6), p.326-330

2010

Volltextzugriff (PDF)

Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls

Journal of Alzheimer's disease, 2010-01, Vol.22 (4), p.1223

2010

Volltextzugriff (PDF)

CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies

Journal of neurology, neurosurgery and psychiatry, 2011, Vol.82 (2), p.160-164

2011

Volltextzugriff (PDF)

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

Neurobiology of aging, 2012-08, Vol.33 (8), p.1599-1608

2012

Volltextzugriff (PDF)

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease

Dementia and geriatric cognitive disorders, 2009-01, Vol.28 (1), p.88

2009

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaPsychiatry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(60)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(52)
Medicin Och Hälsovetenskap
(51)
Science & Technology
(50)
Aged
(48)
Female
(48)
Male
(48)
Life Sciences & Biomedicine
(47)
Medical And Health Sciences
(45)
Neurology
(45)
Psykiatri
(45)
Alzheimer's Disease
(41)
Clinical Medicine
(40)
Klinisk Medicin
(40)
Aged, 80 And Over
(36)
Neurologi
(35)
Neurosciences & Neurology
(34)
Alzheimer Disease - Cerebrospinal Fluid
(33)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(32)
Middle Aged
(32)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

CSF biomarkers predict a more malignant outcome in Alzheimer disease

Low Incidence of Post-Lumbar Puncture Headache in 1,089 Consecutive Memory Clinic Patients

Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls

CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease

Aktive Filter

Suchergebnisse filtern